1995
DOI: 10.1615/critrevtherdrugcarriersyst.v12.i1.10
|View full text |Cite
|
Sign up to set email alerts
|

Biodegradable Microspheres in Drug Delivery

Abstract: General aspects of biodegradable microspheres prepared from natural and synthesized polymers used in drug delivery systems are reviewed first from various viewpoints: characteristics of biodegradable polymers (physicochemical properties, bioerosion mechanism, biocompatibility), preparation method for the microspheres, drug release from parenteral products and briefly nonparenteral products. The relationship between release pattern and pharmacological activity of therapeutic peptides and proteins and rational c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
156
0

Year Published

1999
1999
2019
2019

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 363 publications
(159 citation statements)
references
References 0 publications
3
156
0
Order By: Relevance
“…Poly(lactide-co-glycolide) microparticles (MPs) and nanoparticles (PLGA NPs) have been extensively studied as drug carriers based upon the properties of degradability and biocompatibility [1,2]. Small molecule and biomacromolecular therapeutics, e.g.…”
Section: Introductionmentioning
confidence: 99%
“…Poly(lactide-co-glycolide) microparticles (MPs) and nanoparticles (PLGA NPs) have been extensively studied as drug carriers based upon the properties of degradability and biocompatibility [1,2]. Small molecule and biomacromolecular therapeutics, e.g.…”
Section: Introductionmentioning
confidence: 99%
“…To improve therapeutic efficacy while minimizing side effects, various drug delivery and targeting systems have been investigated such as synthetic polymer-drug conjugates (3), liposomes (4), micelles (5,6), nanogels (7), and micro-or nanosphere (8,9). Nano-sized delivery systems are able to passively accumulate drugs in solid tumors by an enhanced permeation and retention (EPR) effect (10).…”
Section: Introductionmentioning
confidence: 99%
“…PLGA implants are amenable to many compounds, including devices to control thyrotropinreleasing hormone in maintaining metabolism, deliver L-dopa in the treatment of Parkinson's disease, and manage sustained release of luteinizing hormone releasing hormone (LHRH) antagonist to treat prostate cancer (Du 2006;Okada 1995;Sabel et al 1990). Future studies could incorporate various agents to tests their applicability in long-term delivery.…”
Section: Discussionmentioning
confidence: 99%